American Shared Hospital Services (NYSEAMERICAN:AMS) Shares Pass Below 200 Day Moving Average – Here’s What Happened

American Shared Hospital Services (NYSEAMERICAN:AMS)’s stock price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $2.27 and traded as low as $2.08. American Shared Hospital Services shares last traded at $2.10, with a volume of 26,410 shares traded.

American Shared Hospital Services Stock Performance

The firm’s 50 day simple moving average is $2.14 and its 200 day simple moving average is $2.27. The firm has a market capitalization of $13.73 million, a price-to-earnings ratio of -6.18 and a beta of 0.15.

Institutional Investors Weigh In On American Shared Hospital Services

An institutional investor recently bought a new position in American Shared Hospital Services stock. DRW Securities LLC purchased a new stake in American Shared Hospital Services (NYSEAMERICAN:AMS) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 50,481 shares of the company’s stock, valued at approximately $107,000. DRW Securities LLC owned 0.77% of American Shared Hospital Services as of its most recent filing with the SEC. Institutional investors own 23.16% of the company’s stock.

American Shared Hospital Services Company Profile

American Shared Hospital Services operates as a specialized healthcare services company focused on delivering diagnostic imaging solutions to community and rural hospitals across the United States. Through strategic joint ventures and management agreements, the company collaborates with hospital partners to develop and operate outpatient imaging centers that provide advanced modalities while sharing the capital and operating costs. By partnering directly with hospitals, American Shared Hospital Services enables facility owners to offer in-house diagnostic capabilities without the burden of full operational oversight and significant equipment investment.

The company’s service portfolio encompasses a wide range of imaging technologies, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography/computed tomography (PET/CT), mammography, ultrasound, bone densitometry (DEXA) and nuclear medicine.